Nivea responds to nut allergy concerns with kids’ sun protection range

Nivea has responded to concerns from parents and national charity Allergy UK after the recent addition of almond oil to its sun protection range for children.

Nivea: "The almond oil used in our products is refined in a way that there is no known food allergic potential"

National charity Allergy UK issued an alert today (April 22) “to warn parents with children with a nut allergy” that Nivea manufacturer – Beiersdorf – recently added almond oil to its sun protection range for children.

It said it had received calls to its helpline, while people have also taken to social media to warn parents not to use the products if their kids have a nut allergy. 

A spokesperson for Nivea confirmed to C+D that it had indeed added almond oil to the kids’ sun care range this year to “further improve our formulas to provide the best products for our consumers”.

“Almond oil is used in a wide range of formulas for babies and children, as it makes skin soft to touch and protects it from moisture loss,” the spokesperson added.

“The highest standards regarding toxicological testing and the quality of our ingredients and products are essential for Beiersdorf. Please be assured that all ingredients used in our products have been thoroughly evaluated regarding safety and skin compatibility according to the current EU legislation for cosmetics.”

“No known food allergic potential”

Nivea stressed that the almond oil used in its products – including the children’s range – “is refined in a way that there is no known food allergic potential”.

The brand recommended those who have concerns to contact their GP before using the product.

“If in doubt, our NIVEA SUN Babies & Kids Sensitive Protect range may be a more suitable alternative, as it does not contain almond oil,” the spokesperson said.

Sign in or register for free

Latest from News

All the headlines: Community pharmacy funding deal

 
• By 
 • comment

Find out everything you need to know about the government’s plans for community pharmacy – as outlined in this week’s long-awaited pharmacy funding deal.

Pharmacy stop-smoking service expands to ‘non-registered’ staff

 
• By 
 • comment

The new pharmacy contract has expanded who can deliver the smoking cessation service, as well as adding the provision of two drugs via PGDs.

Revealed: 2024/25 contract cash uplift already paid

 
• By 
 • comment

Following this week’s announcement of the long-awaited pharmacy funding deal, C+D has learned that contractors have already received the additional £106 million in retrospective funding for 2024/25.

More from Clinical

exclusive

Exclusive: Pharmacists now able to read patient GP records

 
• By 
 • comment

Community pharmacies now have access to a patient’s GP record at the point of delivering any NHS clinical pharmacy service, C+D has learned.

Semaglutide not linked to increased suicide risk, study finds

 
• By 
 • comment

A new study has revealed that the use of GLP-1RAs such as semaglutide are “not associated” with an increased risk of suicidality among patients with type 2 diabetes.